Lilly set for strong quarter after Novo profit warning
By Patrick Wingrove and Bhanvi Satija (Reuters) -Investors and analysts say they expect Eli Lilly to...
29th July, 2025
By Patrick Wingrove and Bhanvi Satija (Reuters) -Investors and analysts say they expect Eli Lilly to...
29th July, 2025
COPENHAGEN (Reuters) -Obesity drugmaker Novo Nordisk warned on Tuesday that full-year sales and oper...
29th July, 2025
(Reuters) -London's main stock indexes were mixed on Tuesday as investors assessed a spate of mixed...
29th July, 2025
(Reuters) -AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales...
29th July, 2025
By Maggie Fick LONDON (Reuters) -A U.S. ban on copycat versions of Novo Nordisk's Wegovy has begun t...
28th July, 2025
(Reuters) -Italy have withdrawn from the rest of the World University Games in Essen, Germany, after...
25th July, 2025
By Christy Santhosh and Mrinalika Roy (Reuters) -Sarepta Therapeutics failed to win the European dru...
25th July, 2025
(Reuters) -A panel of the European medicines regulator has recommended approving an eco-friendly ver...
25th July, 2025
(Reuters) -The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacap...
25th July, 2025
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutic...
24th July, 2025
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Roche is considering selling its prescription med...
24th July, 2025
By Danilo Masoni MILAN (Reuters) -Global healthcare stocks have not been this cheap in decades and f...
23rd July, 2025